eloralintide tirzepatide Experimental Obesity Drug Helped Some Adults Lose Nearly 50 Pounds Eloralintide | Excenen PharmaTech
Description
Tirzepatide has redefined treatment paradigms for diabetes and obesity
Tirzepatide (Mounjaro) has shown slightly better weight loss results than semaglutide (Ozempic/Wegovy) in clinical trials
It is not intended for patients or other laypersons, nor is it a substitute for medical advice, diagnosis, or treatment
Most human data on tirzepatide in pregnancy, therefore, comes from inadvertent exposures captured in regulatory or observational research
